食物不耐受,食物过敏和IBS:灯光和阴影
Andrea Pasta1, Elena Formisano2,3, Francesco Calabrese1,3
1Gastroenterology Unit, Department of Internal Medicine, University of Genoa, 16132 Genoa, Italy.
Nutrients
|January 23, 2024
概括
刺激性肠综合征 (IBS) 与食物不耐受症密切相关,大多数患者在食用特定食物后会出现症状爆发. 个性化的饮食管理是有效的IBS治疗的关键.
科学领域:
- 胃肠病学 胃肠病学
- 营养科学 营养科学
- 功能性胃肠道疾病 功能性胃肠道疾病
背景情况:
- 刺激性肠综合征 (IBS) 是一种常见的慢性功能性胃肠疾病,其特征是腹痛和改变肠道习惯.
- 全球IBS患病率正在上升,特别是在年轻人中,强调需要有效的管理策略.
- 饮食因素被认为是IBS症状的重要贡献者,高比例的患者报告了与食物相关的恶化.
研究的目的:
- 审查IBS和食物不耐受性之间的复杂关系.
- 探索各种饮食干预措施对IBS症状管理的影响.
- 强调个性化饮食方法在IBS护理中的重要性.
主要方法:
- 这项研究是一个叙事性综述,综合了关于IBS和食物不耐受性的现有文献.
- 它检查了特定饮食模式的作用,包括低FODMAP,无质和地中海饮食.
- 该综述考虑了因剂量依赖反应和复杂的胃肠道生理学而导致的触发性食物识别的挑战.
主要成果:
- 在IBS症状恶化和特定食物的消费之间存在强烈的关联,影响85-90%的患者.
- 鉴定触发性食物是具有挑战性的,因为剂量取决于不耐受性和食物组成的变化.
- 低FODMAP,无质和地中海饮食等饮食模式显示出在控制IBS症状方面的潜力.
结论:
- 准确的诊断和整体方法对于管理IBS至关重要,将饮食因素与胃肠道病理生理学相结合.
- 个性化的饮食管理,考虑到个体的变化和病史,对于有效的治疗至关重要.
- 患者的教育和坚持是至关重要的,承认饮食限制的心理影响和触发因素的变化.
相关概念视频
Irritable Bowel Syndrome I: Introduction
276
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
276
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
334
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
163
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
163
Irritable Bowel Syndrome III: Medical and Nursing Management
208
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
208
Chronic Bowel Disorders: Introduction
455
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
455
Drugs for Treatment of Constipation-Predominant IBS
170
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
170


